Medtronic plc
General ticker "MDT" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $116.5B (TTM average)
Medtronic plc does not follow the US Stock Market performance with the rate: -19.7%.
Estimated limits based on current volatility of 1.3%: low 93.59$, high 96.09$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2026-09-25, amount 0.72$ (Y3.04%)
- Total employees count: 95000 (0.0%) as of 2026
- US accounted for 17.1% of revenue in the fiscal year ended 2025-04-25
- Top business risk factors: Market competition, Regulatory and compliance, Product safety concerns, Cybersecurity threats, Supply chain disruptions
- Price in estimated range
- Earnings for 3 months up through Q1 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-04-24 to 2028-04-23
- 2026-04-24 to 2027-04-24 estimated range: [78.79$, 108.98$]
- 2027-04-24 to 2028-04-23 estimated range: [85.75$, 117.07$]
Financial Metrics affecting the MDT estimates:
- Positive: with PPE of 15.4 at the end of fiscal year the price was neutral
- Positive: 4.90 < Operating cash flow per share per price, % of 6.73
- Positive: 15.80 < Operating profit margin, % of 17.78
- Positive: Inventory ratio change, % of 0.15 <= 0.41
- Positive: -4.49 < Investing cash flow per share per price, % of -2.70
- Positive: 3.48 < Return on assets ratio (scaled to [-100,100]) of 4.94
- Positive: 49.86 < Shareholder equity ratio, % of 53.17 <= 58.56
- Positive: Interest expense per share per price, % of 0.66 <= 0.75
Short-term MDT quotes
Long-term MDT plot with estimates
Financial data
| YTD | 2024-04-26 | 2025-04-25 | 2026-04-24 |
|---|---|---|---|
| Operating Revenue | $32,049.00MM | $33,877.00MM | $36,364.00MM |
| Operating Expenses | $26,905.00MM | $27,922.00MM | $29,897.00MM |
| Operating Income | $5,144.00MM | $5,955.00MM | $6,467.00MM |
| Non-Operating Income | $-307.00MM | $-327.00MM | $-331.00MM |
| Interest Expense | $719.00MM | $729.00MM | $715.00MM |
| R&D Expense | $2,735.00MM | $2,732.00MM | $2,873.00MM |
| Income(Loss) | $4,837.00MM | $5,628.00MM | $6,136.00MM |
| Taxes | $1,133.00MM | $936.00MM | $1,299.00MM |
| Net Income(Loss)* | $3,676.00MM | $4,662.00MM | $4,800.00MM |
| Stockholders Equity | $50,214.00MM | $48,024.00MM | $49,463.00MM |
| Inventory | $5,217.00MM | $5,476.00MM | $5,951.00MM |
| Assets | $89,981.00MM | $91,680.00MM | $93,028.00MM |
| Operating Cash Flow | $6,787.00MM | $7,044.00MM | $7,330.00MM |
| Capital expenditure | $1,587.00MM | $1,859.00MM | $1,904.00MM |
| Investing Cash Flow | $-2,366.00MM | $-1,937.00MM | $-2,934.00MM |
| Financing Cash Flow | $-4,450.00MM | $-4,361.00MM | $-4,751.00MM |
| Earnings Per Share** | $2.77 | $3.63 | $3.74 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.